Institute News
ALL INSTITUTE NEWSThe Miller School at the Alzheimer’s Disease and Parkinson’s Disease International Conference 2026
Miller School researchers at AD/PD 2026 highlighted why APOE is now a leading genetic target for Alzheimer’s treatment.